Four-stranded helix identified in human cells

Quadruplexes may turn instrumental in devising new targeted therapies

Sixty years ago, a research paper was published which was the first to describe the double-helix DNA structure.

Photo: Four-stranded helix identified in human cells

That discovery had been made by James Watson and Francis Crick from the University of Cambridge in the UK. After ten years of investigations, researchers from the same university have now gone public with a paper proving the existence of quadruple structures in the human genome (http://www.cam.ac.uk/research/news/four-stranded-quadruple-helix-dna-structure-proven-to-exist-in-human-cells/). The work, published in Nature Chemistry, shows links between concentrations of four-stranded quadruplexes and DNA replication, which plays a key role in cell division and production.

Scientists believe that targeting quadruplexes with synthetic molecules which trap and contain these DNA structures can prevent cells from replicating their DNA, blocking cell division and halting cell proliferation at the root of cancer. The research „indicates that quadruplexes are more likely to occur in genes of cells that are rapidly dividing, such as cancer cells“, said Prof. Shankar Balasubramanian whose group produced the research. According to the expert from the University of Cambridge’s Department of Chemistry and Cambridge Research Institute, four-stranded structures and their potential for targeted cancer treatment are to serve as a new paradigm for investigation.  (Michael Reiter)

30.01.2013

More on the subject:

Related articles

Photo

News • COVID-related acute kidney injury

COVID-19 vaccination lowers dialysis and mortality risk in patients with COVID-related acute kidney injury

COVID-19 vaccination reduces risk of dialysis and death in patients hospitalized with COVID-related acute kidney injury (AKI), new UCLA research shows. Vaccinated patients were less likely to require…

Photo

News • Fluorescent probe

New visualisation tool targets breast cancer dissemination

In a new study, researchers have developed a new fluorescent probe to visualise signaling dynamics in moving cancer cells, to uncover a new therapeutic possibility for limiting breast cancer spread.

Photo

News • Precision medicine

Melanoma: with 43,000 data points to tailored treatments

Using nine different molecular biological technologies, researchers were able to precisely measure the properties of a melanoma tumor in four weeks and enable a precise treatment decision.

Related products

Subscribe to Newsletter